OR9
Research OR9 with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerOR9
- ExchangeF
- CountryFrance
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Financial periodFY2024
- RevenueEUR 5.04M
- Revenue growth-13.2%
- Net income-EUR 1.93B
- Free cash flow-EUR 3.36M
- Gross margin52.6%
About OR9
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm;
Frequently asked questions
What does OR9 do?
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit;